drugset / Trial / NCT03896971

Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia

NCT03896971

Phase 4 Completed 66 enrolled Safaa AA Khaled Assiut University · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To the investigator's Knowledge this is the first study that will assess Treatment with thrombopoietin Mimetic plus immunosuppressiveTherapy in Egyptian Patients with Aplastic Anaemia. Aim of the work : 1. To evaluate the efficacy, tolerability and toxicity of the combination of thrombopoietin mimetic and immunosuppressive therapy in Egyptian patients with AA. 2. To study the influence of this combination on patients' quality of life. 3. To access evolution to paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndrome , acute leukemia or development of fibrosis

Timeline

Start
2019-11-15
Primary completion
2020-12-01
Completion
2021-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Eltrombopag Small molecule 50 mg Oral
Background Cyclosporine Peptide

Indications